Search for Novo Nordisk AS and
    1. February 3, 2016

      Novo Nordisk lowers earnings targets as drug price pressure grows

      Novo Nordisk has lowered its long-term earnings target and warned investors not to expect further increases in profit...

    2. Fast FT

      February 3, 2016

      European equities sliding, and oil isn't to blame

      European equities are sliding again today, and for a change, oil isn’t to blame. So far in 2016, oil prices and...

    Special Reports

    1. Combating Diabetes

      Urbanisation, poor diet and failure to exercise have led to record levels of obesity, ...
    Search more Special Reports on this topic.

    1. Fast FT

      February 3, 2016

      Novo Nordisk shares hit as FX hedging contracts go awry

      The US dollar has not been a friend recently to Novo Nordisk, the Danish pharmaceuticals company that specialises in...

    2. November 15, 2015

      Novo Nordisk shrugs off diabetes drugs gloom

      Novo Nordisk has vowed to defy the gloom hanging over the diabetes drugs market by gaining market share and avoiding a...

    3. November 14, 2015

      Rapid rise in diabetes linked to spread of urbanisation

      What has caused global incidence of diabetes to more than double since 2000? The obvious answer is unhealthy diet,...

    4. October 12, 2015

      Amazon’s Jeff Bezos plummets down corporate leader rankings

      Jeff Bezos, Amazon’s founder, has slipped from first to 87th in a ranking of the world’s best chief executives, after...

    5. September 22, 2015

      Novo Nordisk to build €70m plant in Iran

      Novo Nordisk is to become the first western pharmaceuticals company to build a manufacturing plant in Iran, in a sign...

    6. August 6, 2015

      Novo Nordisk points to tough China market

      China’s pharmaceuticals market is slowing because of government efforts to contain the rising cost of healthcare and...

    7. April 30, 2015

      Weak euro lifts European drugmakers

      Sanofi and Bayer reported strong first-quarter results and raised guidance for the full year on Thursday, as drugmakers...

    8. March 27, 2015

      Insulin: moving the needle

      It has been a sweet run. The biggest companies in the insulin business — Sanofi, Novo Nordisk, and Eli Lilly — have...

    9. February 2, 2015

      Big pharmaceuticals groups faces biosimilars challenge

      Global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh...

    10. January 25, 2015

      Novo Nordisk to launch weight-loss drug

      Novo Nordisk is preparing a big push behind a new weight-loss treatment that it believes can overcome the reluctance of...

    11. November 17, 2014

      GlaxoSmithKline leads Access to Medicine Index

      GlaxoSmithKline is leading the pharmaceuticals industry in efforts to widen global access to medicines, according to a...

    12. November 13, 2014

      Spread of city life destroys myth of diabetes as a western illness

      Which country has the most diabetics? The US seems the obvious candidate given its high rate of obesity – the main...

    13. November 13, 2014

      Diabetes researchers find hope in link with dementia

      From his office at the Hammersmith Hospital in west London, Dr Paul Edison has begun the search for patients to...

    14. November 13, 2014

      Steps are afoot to supply affordable insulin to the developing world

      The Jutland peninsula in Denmark provides half the world’s supply of insulin, the life-saving pancreatic hormone that...

    15. October 28, 2014

      Sanofi: finding the energy

      Diabetes disrupts the body’s metabolism, sapping it of the energy it needs. Its remedy, insulin, has recently had the...

    16. September 14, 2014

      Novo Nordisk says US more open to obesity drugs

      US regulators are becoming more open to drugs for tackling obesity, says the chief executive of Novo Nordisk, as the...

    17. May 1, 2014

      Novo Nordisk ends streak of double-digit quarterly growth

      Novo Nordisk failed to post quarterly double-digit sales growth for the first time in 12 years, bringing to an end one...

    18. April 1, 2014

      Bristol-Myers Squibb: side effects

      One of these things is not like the others, as Big Bird sings. Look at the mega-cap pharma and biotech stocks. In the...

    19. March 27, 2014

      Baxter: own devices

      Once you’ve played the trump card, what do you do with the rest of your hand? That’s a question Baxter International’s...

    20. March 27, 2014

      Novo Nordisk joins fight against diabetes epidemic in cities

      Novo Nordisk is to team up with some of the world’s biggest cities to find ways of tackling diabetes, amid warnings...

    21. January 3, 2014

      Buy China and Scandinavia, sell France and Turkey

      Like almost everyone else, I’m cautiously optimistic about prospects for 2014. I think we’re in the fairly early stages...

    22. December 10, 2013

      Novo Nordisk reported to police over disclosure delay on ruling

      Novo Nordisk has been reported to the police by the Danish Financial Supervisory Authority for failing to disclose...

    23. November 14, 2013

      Drug manufacturers seek to expand the range of treatments

      Three companies have long dominated the commercial battle over insulin. For nearly a century since it was first...

    24. November 14, 2013

      Universal availability of insulin yet to be achieved

      There are fewer than nine years to go before the centenary of insulin’s introduction in 1922, but David Beran is not...

    25. November 14, 2013

      Diabetes sufferers seek injection of effort

      When Paul Zimmet first conducted research on the island of Nauru nearly four decades ago, he was shocked to find that a...

    26. November 7, 2013

      Novo Nordisk faces headwinds to remain biggest Nordic group

      What is the biggest company in the Nordic region? Measured by market capitalisation, it is not AP Møller-Maersk or...

    27. August 22, 2013

      Eli Lilly drawn into pharmaceutical corruption claims in China

      Eli Lilly became the latest western pharmaceutical group to be drawn into escalating allegations of corruption in...

    28. August 11, 2013

      Comparing drug prices across borders a difficult task

      Comparing the prices of medicines across borders is an intellectual challenge for academics, a profitable business for...

    29. August 8, 2013

      Chinese drugs industry inquiry widens

      Three more western pharmaceutical companies have been drawn into widening Chinese probes into pricing and marketing...

    30. August 8, 2013

      Novo Nordisk raises forecasts amid demand for diabetes treatments

      Novo Nordisk, the Nordic region’s most valuable company by market capitalisation, raised its sales and profit guidance...

    31. July 18, 2013

      Belgian pharma group in China probe

      UCB has become the latest focus of inquiries by Chinese officials in a growing clampdown on drug pricing and marketing...

    32. May 1, 2013

      Novo Nordisk/Lundbeck: drugs start working

      The news from Denmark’s sizeable pharmaceuticals sector has been suitably Nordic noir recently. H Lundbeck, beset by...

    33. April 15, 2013

      Healthcare bucks sell-off in Europe

      Heathcare was the most sought after sector on Monday amid a wider sell-off on global growth concerns that led to...

    34. February 15, 2013

      Renault drives on from dire 2012

      Renault convinced investors this week that it had turned a corner after a dire 2012. The French carmaker said it had a...

    35. February 12, 2013

      FDA rejects Novo Nordisk insulin remedy

      Novo Nordisk lost DKr80bn from its stock market value after the Danish drugs company failed to win US regulatory...

    36. February 11, 2013

      Novo Nordisk ails after drug ruling

      News that Novo Nordisk , the Danish drugs company, failed to win approval for a new drug triggered a strong response...

    37. February 11, 2013

      Novo Nordisk: reality check

      There goes the visibility premium. Novo Nordisk has stood out from rivals in recent years because its growth has been...

    38. January 8, 2013

      Novo Nordisk rises amid Denmark high

      Denmark’s index of leading blue-chip companies reached an all-time high on Tuesday. Copenhagen’s OMX 20 climbed 0.8 per...

    Search for Novo Nordisk AS and

    RELATED VIDEOS

    Videos from FT.com that closely match this topic

    1. Rising insulin sales boost growth at Danish pharma group...
      September 14, 2014

      Rising insulin sales boost growth at Danish pharma group

    2. Lex on Novo Nordisk's failure to win approval on insulin drug...
      February 11, 2013

      Lex on Novo Nordisk's failure to win approval on insuli...